Open AccessWhat is the role of remdesivir in patients with COVID-19?
Author(s) -
John H. Beigel
Publication year - 2021
Publication title -
current opinion in critical care, with evaluated medline/current opinion in critical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.212
H-Index - 88
eISSN - 1080-8183
pISSN - 1070-5295
DOI - 10.1097/mcc.0000000000000866
Subject(s) - medicine , covid-19 , randomized controlled trial , observational study , pandemic , intensive care medicine , clinical trial , coronavirus , emergency medicine , virology , disease , outbreak , infectious disease (medical specialty)
COVID-19 represents an unprecedented public health crisis caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The antiviral remdesivir is one component of treating COVID-19. Unfortunately, the trials evaluating remdesivir have reported mixed results, leading to uncertainty on when to use remdesivir. This review discusses the trials evaluating the efficacy of remdesivir for COVID-19 and other supporting data to help inform the role of remdesivir in patients with COVID-19.